Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · IEX Real-Time Price · USD
2.040
+0.060 (3.03%)
Apr 23, 2024, 3:05 PM EDT - Market open
Acurx Pharmaceuticals Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for ACXP stock has a target of 12, which predicts an increase of 488.24% from the current stock price of 2.04.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 19, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for ACXP is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $14 → $12 | Strong Buy | Maintains | $14 → $12 | +488.24% | Mar 19, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +586.27% | Feb 28, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $13 → $14 | Strong Buy | Maintains | $13 → $14 | +586.27% | Dec 15, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $13 | Strong Buy | Reiterates | $13 | +537.25% | Nov 15, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $13 | Strong Buy | Reiterates | $13 | +537.25% | Sep 13, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.99
from -1.15
EPS Next Year
-2.35
from -0.99
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | n/a | n/a | 50.5M | 3.7M | 53.1M |
Avg | n/a | n/a | 24.7M | 1.8M | 32.6M |
Low | n/a | n/a | 270,480 | n/a | 13.0M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | -85.0% | 2,847.4% |
Avg | - | - | - | -92.7% | 1,705.5% |
Low | - | - | - | - | 618.6% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -1.02 | -2.42 | -3.60 | -0.51 | 0.04 |
Avg | -0.99 | -2.35 | -3.50 | -0.50 | 0.04 |
Low | -0.95 | -2.25 | -3.36 | -0.48 | 0.04 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.